Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized clopidogrel after CABG
ChiCTR-IPR-15007646Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Tongji Hospital. Primary endpoints: Platelet aggregation, Incidence of bleeding and 2 more. Planned start Jan 2016; status: not yet recruiting.
02
Drugs
clopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-15007646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007646.